A reminder of the Rituximab Trials into ME.
Article By Teresa Grøtan in the Publication Kavifondet in April 2015.
What exactly is myalgic encephalopathy (ME), also known as chronic fatigue syndrome (CFS), and how can it be treated? Answers to these questions are being sought by cancer specialists at Norway’s Haukeland University Hospital with support from the Kavli Trust.
By Teresa Grøtan (text and photo)
Senior consultant Øystein Fluge and professor Olav Mella, who heads the hospital’s cancer department, have conducted several studies on treating ME patients with the cancer drug Rituximab. Results from the most recent of these investigations have now been submitted to a medical journal for publication.
To read the rest of this report, click on the link below to go to the article in full: